Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Historical Holders from Q4 2024 to Q3 2025

Symbol
SLXN on Nasdaq
CUSIP
G1281K122
Type / Class
Equity / Ordinary shares, par value $0.0135 per share
Shares outstanding
3.32M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-6
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 4.9% -40% $374K $96.4K 457K +34.7% CVI Investments, Inc. Mar 31, 2025
Lind Global Fund III LP 6.4% -35% $187K -$10.2K 213K -5.16% Lind Global Fund III LP Sep 30, 2025
GOLDMAN SACHS GROUP INC 2.4% -60% $174K $81.8K 212K +88.8% THE GOLDMAN SACHS GROUP, INC. Mar 31, 2025
INTRACOASTAL CAPITAL, LLC 4.99% $172K 210K Mitchell P. Kopin Jan 15, 2025
Lincoln Alternative Strategies LLC 6.18% $127K 131K Lincoln Alternative Strategies LLC Sep 12, 2025
Wildcat Capital Management, LLC 1.3% $110K 113K Wildcat Capital Management, LLC Jun 26, 2025

Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$229K 0
2025 Q2 282K $229K +$32.5K $0.81 6
2025 Q1 236K $260K +$95.7K $1.10 5
2024 Q4 140K $281K +$281K $2.01 3